Literature DB >> 29605526

Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia.

Quinn Grundy1, Roojin Habibi2, Adrienne Shnier3, Christopher Mayes4, Wendy Lipworth5.   

Abstract

"Sunshine" policy, aimed at making financial ties between health professionals and industry publicly transparent, has recently gone global. Given that transparency is not the sole means of managing conflict of interest, and is unlikely to be effective on its own, it is important to understand why disclosure has emerged as a predominant public policy solution, and what the effects of this focus on transparency might be. We used Carol Bacchi's problem-questioning approach to policy analysis to compare the Sunshine policies in three different jurisdictions, the United States, France and Australia. We found that transparency had emerged as a solution to several different problems including misuse of tax dollars, patient safety and public trust. Despite these differences in the origins of disclosure policies, all were underpinned by the questionable assumption that informed consumers could address conflicts of interest. We conclude that, while transparency reports have provided an unprecedented opportunity to understand the reach of industry within healthcare, policymakers should build upon these insights and begin to develop policy solutions that address systemic commercial influence.
Copyright © 2018 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Comparative analysis; Conflict of interest; Disclosure; Pharmaceutical industry; Transparency

Mesh:

Year:  2018        PMID: 29605526     DOI: 10.1016/j.healthpol.2018.03.015

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  15 in total

1.  White paper: statement on conflicts of interest.

Authors:  Julian Bion; Massimo Antonelli; LLuis Blanch; J Randall Curtis; Christiane Druml; Bin Du; Flavia R Machado; Charles Gomersall; Christiane Hartog; Mitchell Levy; John Myburgh; Gordon Rubenfeld; Charles Sprung
Journal:  Intensive Care Med       Date:  2018-09-06       Impact factor: 17.440

2.  Conflicts of interest in medicine: a never-ending story.

Authors:  Livio Garattini; Anna Padula; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2020-03-02       Impact factor: 3.397

3.  Pharmaceutical Industry Support of US Patient Advocacy Organizations: An International Context.

Authors:  So-Yeon Kang; Ge Bai; Laura Karas; Gerard F Anderson
Journal:  Am J Public Health       Date:  2019-02-21       Impact factor: 9.308

4.  Commentary - From Transparency to Accountability: Finding Ways to Make Expert Advice Trustworthy.

Authors:  Quinn Grundy
Journal:  Healthc Policy       Date:  2022-02

5.  Health Services and Policy Research in Canada: An Editor's Reflections.

Authors:  Joel Lexchin
Journal:  Healthc Policy       Date:  2022-02

6.  How the Suboxone Education Programme presented as a solution to risks in the Canadian opioid crisis: a critical discourse analysis.

Authors:  Abhimanyu Sud; Matthew Strang; Daniel Z Buchman; Sheryl Spithoff; Ross E G Upshur; Fiona Webster; Quinn Grundy
Journal:  BMJ Open       Date:  2022-07-12       Impact factor: 3.006

7.  Physicians' attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey.

Authors:  Marlene Stoll; Lara Hubenschmid; Cora Koch; Klaus Lieb; Boris Egloff
Journal:  BMJ Open       Date:  2022-06-24       Impact factor: 3.006

8.  A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.

Authors:  Joel Lexchin; Adriane Fugh-Berman
Journal:  J Gen Intern Med       Date:  2021-03-10       Impact factor: 6.473

9.  Star Trek Offers Insights That Illuminate Actor Engagement in Global Nutrition Governance Comment on "Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool".

Authors:  Vivica I Kraak
Journal:  Int J Health Policy Manag       Date:  2022-02-01

10.  Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry's Disclosure UK database, 2015 and 2016 cohorts.

Authors:  Shai Mulinari; Piotr Ozieranski
Journal:  BMJ Open       Date:  2018-10-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.